Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease

被引：0
|
作者：
Zhang Xin [1 ,2 ,3 ,4 ]
Yu Xiaojuan [1 ,2 ,3 ,4 ]
Wang Suxia [1 ,2 ,3 ,4 ,5 ]
Dong Yujun [6 ]
Zhao Minghui [1 ,2 ,3 ,4 ,7 ]
Zhou Fude [1 ,2 ,3 ,4 ]
机构：
[1] Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China
[2] Institute of Nephrology, Peking University, Beijing, China
[3] Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
[4] Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China
[5] Laboratory of Electron Microscopy, Pathological Centre, Peking University First Hospital, Beijing, China
[6] Hematological Division, Department of Medicine, Peking University First Hospital, Beijing, China
[7] Peking-Tsinghua Center for Life Science, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing,
来源：
中华医学杂志英文版 | 2025年 / 138卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R692 [肾疾病];
学科分类号：
摘要：
<正>
引用
收藏
相关论文
共 50 条
  • [1] Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease
    Zhang, Xin
    Yu, Xiaojuan
    Wang, Suxia
    Dong, Yujun
    Zhao, Minghui
    Zhou, Fude
    CHINESE MEDICAL JOURNAL, 2025, 138 (02) : 246 - 248
  • [2] Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function
    Milani, Paolo
    Basset, Marco
    Curci, Paola
    Foli, Andrea
    Rizzi, Rita
    Nuvolone, Mario
    Guido, Raffaella
    Gesualdo, Loreto
    Specchia, Giorgina
    Merlini, Giampaolo
    Palladini, Giovanni
    BLOOD ADVANCES, 2020, 4 (07) : 1321 - 1324
  • [3] Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease
    Kastritis, Efstathios
    Rousakis, Pantelis
    Kostopoulos, Ioannis, V
    Gavriatopoulou, Maria
    Theodorakakou, Foteini
    Fotiou, Despina
    Dialoupi, Ioanna
    Migkou, Magdalini
    Roussou, Maria
    Kanellias, Nikolaos
    Tselegkidi, Maria-Irini
    Eleutherakis-Papaiakovou, Evangelos
    Papanikolaou, Asimina
    Gakiopoulou, Charikleia
    Psimenou, Erasmia
    Spyropoulou-Vlachou, Marylin
    Gatou, Anastasia
    Terpos, Evangelos
    Tsitsilonis, Ourania
    Dimopoulos, Meletios A.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (04): : 259 - 266
  • [4] The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis
    Said, Samar M.
    Rocha, Alejandro Best
    Valeri, Anthony M.
    Paueksakon, Paisit
    Dasari, Surendra
    Theis, Jason D.
    Vrana, Julie A.
    Obadina, Modupe O.
    Saghafi, Darius
    Alexander, Mariam Priya
    Sethi, Sanjeev
    Larsen, Christopher P.
    Joly, Florent
    Dispenzieri, Angela
    Bridoux, Frank
    Sirac, Christophe
    Leung, Nelson
    Fogo, Agnes B.
    McPhail, Ellen D.
    Nasr, Samih H.
    KIDNEY INTERNATIONAL, 2022, 101 (01) : 152 - 163
  • [5] Hematologic Responses in Patients with Heavily Pretreated Light Chain Deposition Disease (LCDD) Receiving Daratumumab
    Milani, Paolo
    Basset, Marco
    Foli, Andrea
    Merlini, Giampaolo
    Palladini, Giovanni
    BLOOD, 2018, 132
  • [6] LIGHT-CHAIN DEPOSITION DISEASE OF THE KIDNEY - MORPHOLOGICAL ASPECTS IN 24 PATIENTS
    STROM, EH
    FOGAZZI, GB
    BANFI, G
    POZZI, C
    MIHATSCH, MJ
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1994, 425 (03): : 271 - 280
  • [7] Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement
    Minarik, Jiri
    Scudla, Vlastimil
    Tichy, Tomas
    Pika, Tomas
    Bacovsky, Jaroslav
    Lochman, Pavel
    Zadrazil, Josef
    LEUKEMIA & LYMPHOMA, 2012, 53 (02) : 330 - 331
  • [8] Amyloidosis, extramedullary plasmacytoma, and light chain deposition disease: impressive results of daratumumab therapy
    Wiklik-Dziadek, Magdalena
    Jaworek-Troc, Joanna
    Jurczyszyn, Artur
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 297 - 298
  • [9] Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment
    Gounot, Romain
    Le Bras, Fabien
    Dupuis, Jehan
    Oghina, Silvia
    Bodez, Diane
    Roulin, Louise
    Maarek, Alizee
    Ladaique, Amandine
    Beldi-Ferchiou, Asma
    Poullot, Elsa
    Molinier-Frenkel, Valerie
    Haioun, Corinne
    Damy, Thibaud
    Belhadj, Karim
    Lemonnier, Francois
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 979 - 983
  • [10] A Unique Presentation of Light Chain Deposition Disease: Kidney Disease With No Proteinuria
    Debnath, Dipanjan
    Zhuang, Eric
    Hassan, Abdulahi
    Pizzi, Erica
    Mehdi, Ali
    Esan, Olukemi
    Raza, Shahzad
    Mewawalla, Prerna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S205 - S206
12345